Showing results (1151-1160 of 1,186) with videos related to

Sort By:
Pageof 119
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 7, 2004
Reproductive factors and risk of glioma in womenKui Huang, Elizabeth A Whelan, Avima M Ruder, et al.
Medrxiv : the Preprint Server for Health Sciences|June 5, 2026
Tobacco Use is Related to Parietal-Hippocampal Connectivity in People at Clinical High Risk for PsychosisYunong Bai, Maxwell J Roeske, Adam Beermann, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 22, 2008
Elevated globotriaosylsphingosine is a hallmark of Fabry diseaseJohannes M Aerts, Johanna E Groener, Sijmen Kuiper, et al.
Oncotarget|May 10, 2015
Activation of hypoxia signaling induces phenotypic transformation of glioma cells: implications for bevacizumab antiangiogenic therapyHui Xu, Shervin Rahimpour, Cody L Nesvick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2008
Phase I/II trial of erlotinib and temozolomide with radiation therapy in the treatment of newly diagnosed glioblastoma multiforme: North Central Cancer Treatment Group Study N0177Paul D Brown, Sunil Krishnan, Jann N Sarkaria, et al.
Forensic Science International. Genetics|September 11, 2015
52 additional reference population samples for the 55 AISNP panelAndrew J Pakstis, Eva Haigh, Lotfi Cherni, et al.
Medrxiv : the Preprint Server for Health Sciences|September 26, 2025
Cannabis and Tobacco Co-Use Predicts Psychosis in Clinical High Risk CohortsDaniel Bello, Sophia H Blyth, Rachel A Rabin, et al.
Nature. Mental Health|June 15, 2026
Cannabis and tobacco co-use predicts psychosis in clinical high risk cohortsDaniel Bello, Sophia H Blyth, Rachel A Rabin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 15, 2016
Repeated measures analyses of dermatitis symptom evolution in breast cancer patients receiving radiotherapy in a phase 3 randomized trial of mometasone furoate vs placebo (N06C4 [alliance])Terence T Sio, Pamela J Atherton, Brandon J Birckhead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 7, 2014
FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutationGeoffrey Kim, Amy E McKee, Yang-Min Ning, et al.
Pageof 119